Dean G Brown (Dean Brown)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Trypanosoma Cruzi

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

ACS chemical biology

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Dean G Brown
A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. Journal of medicinal chemistry 67 (3) (2024)
Dean G Brown
A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. Journal of medicinal chemistry 67 (3) (2024)
Dean G Brown
A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. Journal of medicinal chemistry (2024)
Dean G Brown, Nicholas A Meanwell, Dennis C Liotta
Some Observations and Guidance on Perspectives in the Journal of Medicinal Chemistry . Journal of medicinal chemistry 66 (4) (2023)
Dean G Brown, Nicholas A Meanwell, Dennis C Liotta
Some Observations and Guidance on Perspectives in the Journal of Medicinal Chemistry . Journal of medicinal chemistry 66 (4) (2023)
Dean G Brown, Nicholas A Meanwell, Dennis C Liotta
Some Observations and Guidance on Perspectives in the Journal of Medicinal Chemistry . Journal of medicinal chemistry (2023)
Dean G Brown, Nicholas A Meanwell, Dennis C Liotta
Some Observations and Guidance on Perspectives in the Journal of Medicinal Chemistry . Journal of medicinal chemistry 66 (4) (2023)
Dean G Brown
An Analysis of Successful Hit-to-Clinical Candidate Pairs. Journal of medicinal chemistry (2023)
Dean G Brown
Correction to "An Analysis of Successful Hit-to-Clinical Candidate Pairs". Journal of medicinal chemistry (2023)
Tyler Heitmann, Gangling Liao, Pablo de León, Glen Ernst, Ingrid Buchler, Huijun Wei, Evgeny Shlevkov, Dean G Brown, Martina Fitzek, Matthew Collier, David M Smith, James C Barrow
Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
Dean G Brown
Adapting to the Changing Landscape of Biotech-Driven Drug Discovery. Journal of medicinal chemistry (2023)
Tyler Heitmann, Gangling Liao, Pablo de León, Glen Ernst, Ingrid Buchler, Huijun Wei, Evgeny Shlevkov, Dean G Brown, Martina Fitzek, Matthew Collier, David M Smith, James C Barrow
Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
Dean G Brown, Heike J Wobst
A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions. Journal of medicinal chemistry 64 (5) (2021)
Samantha N Muellers, Juliana A Gonzalez, Abinash Kaur, Vital Sapojnikov, Annie Laurie Benzie, Dean G Brown, David W Parkin, Brian J Stockman
Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase. ACS infectious diseases 5 (3) (2019)
Dean G Brown, Heike J Wobst
Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research. Journal of medicinal chemistry 63 (5) (2019)
Dean G Brown, Graham F Smith, Heike J Wobst
Promiscuity of in Vitro Secondary Pharmacology Assays and Implications for Lead Optimization Strategies. Journal of medicinal chemistry 63 (12) (2019)
Aarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, Arjan Snijder, Niek Dekker, Dean G Brown, Thomas Lundbäck, Andrew X Zhang, M Paola Castaldi
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins. ACS chemical biology 14 (9) (2019)
Dean G Brown, Jonas Boström
Where Do Recent Small Molecule Clinical Development Candidates Come From? Journal of medicinal chemistry 61 (21) (2018)